6--16-- COMBINATION OF A 6-OXO-16-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR
N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물. A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Korean |
Published |
07.08.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물.
A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide. |
---|---|
AbstractList | N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물.
A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide. |
Author | BLADT FRIEDHELM FRIESE HAMIM MANJA |
Author_xml | – fullname: BLADT FRIEDHELM – fullname: FRIESE HAMIM MANJA |
BookMark | eNqNyr0KwjAUhuEOOvh3DwecA_GHSsfTJG0OYiIhVOtSisRJ2mK9f4zgBTh8fMPzzpNJ13dhlrxSxjZxIOwpJ4OerAFbAELK7NV-TZKupbPsXDuSeCOjQCpHVWwrBRorMiWg8cQEGqEcoIhCvoYLeR0FVFk4IKMpJ2_dMpk-2ucYVr9fJOtCeaFZGPomjEN7D114N0e35ZsD5xnfZxnu_qs-xUo58Q |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | EGFR 억제제와 항암 활성을 갖는 6-옥소-1,6-디히드로-피리다진 유도체의 조합 |
ExternalDocumentID | KR20170090499A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20170090499A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:57:00 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20170090499A3 |
Notes | Application Number: KR20177018885 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170807&DB=EPODOC&CC=KR&NR=20170090499A |
ParticipantIDs | epo_espacenet_KR20170090499A |
PublicationCentury | 2000 |
PublicationDate | 20170807 |
PublicationDateYYYYMMDD | 2017-08-07 |
PublicationDate_xml | – month: 08 year: 2017 text: 20170807 day: 07 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | MERCK PATENT GMBH |
RelatedCompanies_xml | – name: MERCK PATENT GMBH |
Score | 3.0607648 |
Snippet | N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | 6--16-- COMBINATION OF A 6-OXO-16-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170807&DB=EPODOC&locale=&CC=KR&NR=20170090499A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMMwp6ptOxY8pAaVvwa72Y30o0jbtGseaEWrdfBlrm4Eo29gq_n2TbtM97SGQ5EJIDi53l_sC4EHVc9syxhxlbdVAulGoKJsUHGlaYWgWn3C7inLtxWb0qr8MjEENfG1iYao8oT9VckRBUbmg97J6r-f_n1i48q1cPmYfYmr2HCYOVtbaccsSApClYM8J-hRTX_F9p8uUmK1gqi0FfHcP7AtB2pL0EKSejEuZbzOV8AQc9MV-0_IU1D5nDXDkb2qvNcBhb23yFt019S3PwMJEqCUa9GnPI6s8tpCG0IUmogMqYZhEQ8wo6g8Zwe47iQOIhaqWirVpACM3JXEHunFCkC-r0jAonUhSkgzhG0kiAYFBJ2SQxBHxSELZObgPg8SPkDj86A9Xoy7bvunTBahPZ1N-CaBg89zMMt2Wtkyu5nZhtXO10AuN83xsFFeguWun693gG3Ash5VnnNUE9XLxzW8Fty6zuwrJv_dQjn8 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8QjXhT1PiB2kSzW-OY-2AHYrZ1YxW2kWZO8ELYVhKjAQIz_vu2A5QThyZNf81L2-T1vdf3UQAeZDUzDW3MUNqSNaRquYzSSc6QouSaYrAJM8ss1yDU_Vf1ZaANKuBrkwtT1gn9KYsjco7KOL8X5X09_3_EwmVs5fIx_eBDs2cvbmNpbR03Da4AGRK2224_wpEjOU67S6WQrjDZFAq-tQf2uZJtCH5wE1vkpcy3hYp3DA76nN60OAGVz1kd1JzN32t1cBisXd68u-a-5SlY6Ag1eYNOFNhkVccWRh60oI6iQSQwTPwhphHqDynB1jsJXYi5qZbwuYkLfSshYQdaYUyQI36loVAEkSQkHsI3EvscgW7Ho5CEPrFJHNEzcO-5seMjvvjR31mNunR7p0_noDqdTdkFgFzMMz1NVVP4MpmcmbnRyuRczRXGsrGWX4LGLkpXu-E7UPPjoDfqkbB7DY4EVEbJGQ1QLRbf7IZL7iK9LQ_8F9NckXI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=6--16--+COMBINATION+OF+A+6-OXO-16-DIHYDRO-PYRIDAZINE+DERIVATIVE+HAVING+ANTI-CANCER+ACTIVITY+WITH+AN+EGFR+INHIBITOR&rft.inventor=BLADT+FRIEDHELM&rft.inventor=FRIESE+HAMIM+MANJA&rft.date=2017-08-07&rft.externalDBID=A&rft.externalDocID=KR20170090499A |